UroGen Pharma URGN Total debt

Total debt at other companies

Bristol-Myers SquibbBMY

$43.33B-12.3%

PfizerPFE

$64.43B+4.9%

Johnson & JohnsonJNJ

$49.04B-3.4%

Merck & Co.MRK

$56.73B+54.0%

ImmunityBio, Inc.IBRX

$445.39M+32.2%

Aura Biosciences, Inc.AURA

$16.99M-7.9%

FAQ

What is UroGen Pharma's total debt?

UroGen Pharma (URGN) reported total debt of $197.54M in Q2 2026.

How has UroGen Pharma's total debt changed year-over-year?

UroGen Pharma's total debt increased by 55.0% year-over-year, from $127.47M to $197.54M.

What is the long-term trend for UroGen Pharma's total debt?

Over 5 years (2020 to 2025), UroGen Pharma's total debt has grown at a 117.5% compound annual growth rate (CAGR), from $2.7M to $131.36M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.